These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22503362)

  • 1. New description of protein-ligand interactions using a spherical self-organizing map.
    Hasegawa K; Funatsu K
    Bioorg Med Chem; 2012 Sep; 20(18):5410-5. PubMed ID: 22503362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Method for Mapping the Molecular Surface of a Protein Structure Using a Spherical Self-Organizing Map.
    Hasegawa K; Funatsu K
    Mol Inform; 2012 Feb; 31(2):161-6. PubMed ID: 27476960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2-benzisothiazol-3-one derivatives as a novel class of small-molecule caspase-3 inhibitors.
    Wu L; Lu M; Yan Z; Tang X; Sun B; Liu W; Zhou H; Yang C
    Bioorg Med Chem; 2014 Apr; 22(8):2416-26. PubMed ID: 24656804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors.
    Srivani P; Srinivas E; Raghu R; Sastry GN
    J Mol Graph Model; 2007 Jul; 26(1):378-90. PubMed ID: 17307372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel class of small-molecule caspase-3 inhibitors prepared by multicomponent reactions.
    Zhu Q; Gao L; Chen Z; Zheng S; Shu H; Li J; Jiang H; Liu S
    Eur J Med Chem; 2012 Aug; 54():232-8. PubMed ID: 22652225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors.
    Li Z; Pan Y; Zhong W; Zhu Y; Zhao Y; Li L; Liu W; Zhou H; Yang C
    Bioorg Med Chem; 2014 Dec; 22(24):6735-45. PubMed ID: 25468037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7.
    Agniswamy J; Fang B; Weber IT
    Apoptosis; 2009 Oct; 14(10):1135-44. PubMed ID: 19655253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supervised self-organizing maps in drug discovery. 1. Robust behavior with overdetermined data sets.
    Xiao YD; Clauset A; Harris R; Bayram E; Santago P; Schmitt JD
    J Chem Inf Model; 2005; 45(6):1749-58. PubMed ID: 16309281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis.
    Pan D; Liu J; Senese C; Hopfinger AJ; Tseng Y
    J Med Chem; 2004 Jun; 47(12):3075-88. PubMed ID: 15163189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating molecular shape into the alignment-free Grid-Independent Descriptors.
    Fontaine F; Pastor M; Sanz F
    J Med Chem; 2004 May; 47(11):2805-15. PubMed ID: 15139758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between Molecular Complexity, Biological Activity, and Structural Diversity.
    Schuffenhauer A; Brown N; Selzer P; Ertl P; Jacoby E
    J Chem Inf Model; 2006; 46(2):525-35. PubMed ID: 16562980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of scoring functions using 3D molecular fields. Mapping the diacyl-hydrazine-binding pocket of an insect ecdysone receptor.
    Bordas B; Belai I; Lopata A; Szanto Z
    J Chem Inf Model; 2007; 47(1):176-85. PubMed ID: 17238263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Searching for a reliable orientation of ligands in their binding site: comparison between a structure-based (Glide) and a ligand-based (FIGO) approach in the case study of PDE4 inhibitors.
    Gratteri P; Bonaccini C; Melani F
    J Med Chem; 2005 Mar; 48(5):1657-65. PubMed ID: 15743207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors.
    Liu D; Tian Z; Yan Z; Wu L; Ma Y; Wang Q; Liu W; Zhou H; Yang C
    Bioorg Med Chem; 2013 Jun; 21(11):2960-7. PubMed ID: 23632366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compressed images for affinity prediction-2 (CIFAP-2): an improved machine learning methodology on protein-ligand interactions based on a study on caspase 3 inhibitors.
    Erdas O; Andac CA; Gurkan-Alp AS; Alpaslan FN; Buyukbingol E
    J Enzyme Inhib Med Chem; 2015; 30(5):809-15. PubMed ID: 25578823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.